Arch Chemicals posted a surprise quarterly profit as higher pricing and the favorable impact of a recent acquisition offset lower volumes and unfavorable foreign exchange. Net income for the quarter was $3.2 million, or 13 cents a share, compared with $5.7 million, or 23 cents a share, in the same quarter last year. Sales fell 15 % to $293.7 million.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
Compelling solutions through strategic partnerships
Ineos CEO Ineos calls on European politicians to save the chemical industry.
